
Pharmafocus: Advances in Oncology available now!
pharmafile | September 30, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Pharmafocus, oncology, pharmafocus supplementÂ
The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the latest in tumour research and treatment.
Inside you can find a range of valuable insight from industry experts. Anjali Shukla investigates checkpoint inhibitor drugs and how they may be paving a path to a cancer cure by influencing the human immune system, and Sean Murray speaks to Dr Ugur Sahin, CEO of BioNTech to discuss the rapidly approaching possibility of a universal cancer vaccine.
Also in the issue, AbbVie’s VP of oncology clinical development brings some encouraging signs from the blood cancer space, and Cancer Research UK’s Dr Rowena Sharp and Dr Catrin Middleton delve into the crucial area of precision medicine and how progress in the field is leading us ever-closer to truly personalised cancer care.
Related Content

START and Rome cancer institute partner to expand early-phase trial access in Italy
The START Center for Cancer Research is partnering with Rome-based Istituti Fisioterapici Ospitalieri (IFO) to …

Highlighting the value of lab research for healthcare innovation
Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory …

Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …




